In an effort to find new ways of inhibiting the reverse transcriptase enzyme in HIV-1, a University of Missouri at Columbia-led team turned to high-throughput sequencing in combination with a type of RNA enrichment known as "systematic evolution of ligands through exponential enrichment," or SELEX.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Related Posts

This Week in Nature

Be Gone

This Week in PLOS

This Week in Cell

This Week in PLOS

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.